SCHILLER - High-quality cardiac medical technology

The battle against cardiac death need not seem like a burden too heavy to bear, especially not with new, compact and lightweight equipment from SCHILLER.


For more than four decades, SCHILLER has been committed to the fight against sudden cardiac death. While the most established manufacturers were still selling heavy and bulky emergency devices, SCHILLER launched a sophisticated emergency electrocardioscope that was ten times lighter. In one stroke, the company not only developed a solid reputation, but also set new standards in medical care.


Two years later, the company developed the smallest emergency ECG device on the market - with an integrated printer. A microcomputer built into the device allows the automatic measurement and interpretation of the ECG. This in turn enables the early detection of heart disorders. Thanks to suitable therapies and rehabilitation measures, physicians can now protect people of all ages from sudden cardiac death.


As success grew, so did its product portfolio. SCHILLER developed devices such as blood-pressure monitors and spirometers, which added to its success, Nowadays SCHILLER produces complete diagnostic stations and monitoring devices for clinics and medical practices. The company has also expanded its production sites and competence centres.


In addition to the headquarters in Baar, Switzerland, a competence centre has been established in Wissembourg, France, and specialises in the fields of defibrillation and monitoring. Another competence centre opened in Graz in Austria. The company medilog became part of the SCHILLER group. This new alliance allowed SCHILLER to acquire additional knowledge in the field of high-end and long-term ECG, which has helped them to remain leaders in the industry.


The next major step was achieved in 2014, through the alliance with the company Ganshorn, specialising in the field of pulmonary function diagnostics. At a time when pulmonology and cardiology are moving closer together, clever and combined solutions are required. Both leading companies recognised this market need early on and consequently decided to consolidate their long-term collaboration. SCHILLER has now acquired the majority of the share capital of Ganshorn.


SCHILLER has developed unique products, such as FRED easyport, the world's smallest defibrillator, or the fire of life software, which analyses the autonomic nervous system. The HRV (heart rate variability) is analysed and the patient's condition is displayed in the fire of life graphics. These graphics show how well the patient can cope with stress and how he reacts to rest. This opens up new diagnostic possibilities, reducing burnout. However, resting on its laurels is not an option for SCHILLER, because innovation is a priority for this Swisscompany. Two of the latest developments are new ECG devices.

CARDIOVIT FT-1
This machine delivers the maximum performance in compact electrocardiographs. Designed for users who value state-of-the-art technology, SCHILLER's CARDIOVIT FT-1 offers:

  • power and flexibility of a PC in a portable ECG
  • bidirectional Wi-Fi communication to EMR
  • culprit coronary artery algorithm for early stemi detection.

CARDIOVIT AT-170
Robustly designed, SCHILLER's new high-end electrocardiograph completes the proven AT product range. It brings a sturdy design to the busiest hospitals, as well as a combination of applications that makes it the ideal multi-use workstation for private practices:

  • wide high-resolution touchscreen for easy ECG review
  • full-size keyboard with a durable cover keeping dust, dirt and liquids away, making it highly hygienic
  • ETM Sport - the first automated interpretation of athletes' ECGs based on the Seattle Criteria.

Products and Services

Contact Details

SCHILLER
URL: www.schiller.ch

Make An Enquiry
First Name

Last Name

Email Address

Enquiry


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.